BRIEF published on 03/02/2026 at 16:30, 3 hours 35 minutes ago Sartorius Stedim Biotech: Statement on Share Capital Share Capital Voting Rights Actions Sartorius Stedim Biotech AMF Regulations
BRIEF published on 03/02/2026 at 16:30, 3 hours 35 minutes ago Sartorius Stedim Biotech: Share Capital and Voting Rights Update Share Capital Voting Rights French Commercial Code Sartorius Stedim Biotech EQS News Service
PRESS RELEASE published on 03/02/2026 at 16:25, 3 hours 40 minutes ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares number of shares and voting rights in issued capital as of February 28, 2026 Voting Rights Capital Déclaration Shares Sartorius Stedim Biotech
PRESS RELEASE published on 02/16/2026 at 09:13, 14 days 10 hours ago Sartorius Stedim Biotech releases Universal Registration Document 2025 Sartorius Stedim Biotech releases Universal Registration Document 2025, providing insights into its financial performance and strategic outlook for the future Financial Report Sartorius Stedim Biotech Annual Results Universal Registration Document Biopharma Industry
BRIEF published on 02/16/2026 at 09:13, 14 days 10 hours ago Sartorius Stedim Biotech publishes its 2025 Universal Registration Document Consolidated Financial Statements Sartorius Stedim Biotech Universal Registration Document Fiscal Year 2025 2026 Objectives
BRIEF published on 02/16/2026 at 09:13, 14 days 10 hours ago Sartorius Stedim Biotech Releases 2025 Universal Registration Document Global Operations Sartorius Stedim Biotech Universal Registration Document Biopharmaceutical Solutions 2025 Financials
PRESS RELEASE published on 02/16/2026 at 09:09, 14 days 10 hours ago Sartorius Stedim Biotech SA: Information on Document Availability Sartorius Stedim Biotech releases Universal Registration Document 2025 with business development and financial statements. Leading biopharmaceutical partner based in Aubagne, France Financial Statements Business Development Sartorius Stedim Biotech Biopharmaceutical Industry Universal Registration Document
PRESS RELEASE published on 02/16/2026 at 09:08, 14 days 10 hours ago Sartorius Stedim Biotech SA: Information on Document Availability Sartorius Stedim Biotech Group's Universal Registration Document 2025 now available at the provided link. Includes fiscal 2025 business development, 2026 forecast, and financial statements Financial Statements Investor Relations Sartorius Stedim Biotech Biopharmaceutical Industry Universal Registration Document 2025
BRIEF published on 02/06/2026 at 11:50, 24 days 8 hours ago Sartorius Stedim Biotech Proposes Steady Dividend for 2025 Biotech Industry Dividend Proposal Sartorius Stedim Biotech Annual Shareholders' Meeting 2025 Financial Results
BRIEF published on 02/06/2026 at 11:50, 24 days 8 hours ago Sartorius Stedim Biotech proposes a dividend of €0.69 Financial Results Sartorius Stedim Biotech General Assembly Aubagne 2025 Dividend
Published on 03/02/2026 at 18:35, 1 hour 30 minutes ago Electrovaya Announces Results of Annual Meeting of Shareholders
Published on 03/02/2026 at 17:40, 2 hours 25 minutes ago Bioxytran, Inc. Reports Positive Phase 1b/2a Clinical Study Results for ProLectin-M, a Broad-Range Antiviral Drug in Mild to Moderate COVID-19
Published on 03/02/2026 at 16:00, 4 hours 5 minutes ago MWC 2026: Amdocs Announces Research Collaboration with Stanford Researchers to Study AI's Impact on Software Engineering Productivity
Published on 03/02/2026 at 15:22, 4 hours 43 minutes ago Silver Spruce Resources Inc. Announces Non-Brokered Private Placement for Proceeds of up to $2,000,000
Published on 03/02/2026 at 19:50, 15 minutes ago EQS-Adhoc: Beiersdorf Aktiengesellschaft: Guidance 2026 –– New Share Buyback Program
Published on 03/02/2026 at 19:07, 58 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/02/2026 at 18:30, 1 hour 35 minutes ago United States (U.S.) Secretary of Energy Chris Wright is back to Powering Africa Summit 2026 to discuss energy access and clean cooking
Published on 03/02/2026 at 18:05, 2 hours ago Huawei Cloud Summit at MWC26: Solving Industry Challenges with AI
Published on 03/02/2026 at 17:35, 2 hours 30 minutes ago Disclosure of transactions in own shares from February 23 to February 27, 2026
Published on 03/02/2026 at 08:45, 11 hours 20 minutes ago Imerys: 2025 consolidated financial statements
Published on 02/27/2026 at 23:00, 2 days 21 hours ago Biophytis increases to €2 million the ceiling of its bond facility with Hexagon Capital Fund
Published on 02/27/2026 at 18:02, 3 days 2 hours ago AXA: Execution of a share repurchase agreement in relation to AXAs share buy-back program of up to Euro 1.25 billion
